Published in Proc Natl Acad Sci U S A on January 25, 2005
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol (2010) 3.19
Prions. Cold Spring Harb Perspect Biol (2011) 3.17
Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem (2009) 2.80
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69
Prion recognition elements govern nucleation, strain specificity and species barriers. Nature (2007) 2.57
The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J (2008) 2.43
Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A (2012) 1.77
Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66
The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem (2008) 1.64
Biology and genetics of prions causing neurodegeneration. Annu Rev Genet (2013) 1.63
Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci (2005) 1.62
Amyloid structure: conformational diversity and consequences. Annu Rev Biochem (2011) 1.57
Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog (2011) 1.53
Prions on the move. EMBO Rep (2011) 1.47
The expanding universe of prion diseases. PLoS Pathog (2006) 1.45
Search for a prion-specific nucleic acid. J Virol (2005) 1.44
Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A (2008) 1.43
Inactivation of prions by acidic sodium dodecyl sulfate. J Virol (2006) 1.43
Prion hypothesis: the end of the controversy? Trends Biochem Sci (2010) 1.40
The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta (2006) 1.39
Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J (2007) 1.28
Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol (2008) 1.27
A new mechanism for transmissible prion diseases. J Neurosci (2012) 1.25
De novo generation of prion strains. Nat Rev Microbiol (2011) 1.17
Stabilization of a prion strain of synthetic origin requires multiple serial passages. J Biol Chem (2012) 1.13
Relationship between conformational stability and amplification efficiency of prions. Biochemistry (2011) 1.11
Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog (2011) 1.06
Biological and biochemical characterization of L-type-like bovine spongiform encephalopathy (BSE) detected in Japanese black beef cattle. Prion (2008) 1.03
Is tau ready for admission to the prion club? Prion (2012) 1.01
Switching in amyloid structure within individual fibrils: implication for strain adaptation, species barrier and strain classification. FEBS Lett (2009) 1.00
Changes in prion replication environment cause prion strain mutation. FASEB J (2013) 0.99
Convergent replication of mouse synthetic prion strains. Am J Pathol (2013) 0.98
Developmental expression of PrP in the post-implantation embryo. Brain Res (2006) 0.97
Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem. Front Neurol (2013) 0.96
Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification. PLoS One (2012) 0.95
Conformation determines the seeding potencies of native and recombinant Tau aggregates. J Biol Chem (2014) 0.95
Intraspecies prion transmission results in selection of sheep scrapie strains. PLoS One (2010) 0.93
Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A (2006) 0.93
NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS One (2010) 0.92
The [RNQ+] prion: a model of both functional and pathological amyloid. Prion (2011) 0.91
Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol (2010) 0.89
Generation of prions in vitro and the protein-only hypothesis. Prion (2010) 0.88
Nanoimaging for prion related diseases. Prion (2010) 0.87
Probing the conformation of a prion protein fibril with hydrogen exchange. J Biol Chem (2010) 0.85
The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain. J Virol (2009) 0.85
Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. J Virol (2011) 0.84
Chemical and biophysical insights into the propagation of prion strains. HFSP J (2008) 0.83
Lipopolysaccharide induced conversion of recombinant prion protein. Prion (2014) 0.83
Prion propagation in vitro: are we there yet? Int J Med Sci (2008) 0.82
The many shades of prion strain adaptation. Prion (2014) 0.82
Prion infection: seeded fibrillization or more? Prion (2008) 0.81
Ovine plasma prion protein levels show genotypic variation detected by C-terminal epitopes not exposed in cell-surface PrPC. Biochem J (2006) 0.80
De novo mammalian prion synthesis. Prion (2009) 0.79
PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases. Mol Neurodegener (2010) 0.79
Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions. Sci Rep (2015) 0.79
Investigating the conformational stability of prion strains through a kinetic replication model. PLoS Comput Biol (2009) 0.79
Potential mechanisms and implications for the formation of tau oligomeric strains. Crit Rev Biochem Mol Biol (2016) 0.79
A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner. J Virol (2013) 0.79
De novo prions. F1000 Biol Rep (2010) 0.78
Emergence of a novel bovine spongiform encephalopathy (BSE) prion from an atypical H-type BSE. Sci Rep (2016) 0.78
Synthetic prions with novel strain-specified properties. PLoS Pathog (2015) 0.77
Mapping the prion protein distribution in marsupials: insights from comparing opossum with mouse CNS. PLoS One (2012) 0.76
Heterogeneity of the Abnormal Prion Protein (PrPSc) of the Chandler Scrapie Strain. Pathogens (2013) 0.76
Insights into prion biology: integrating a protein misfolding pathway with its cellular environment. Prion (2011) 0.75
Getting to the core of prion superstructural variability. Prion (2016) 0.75
Commentary: A bacterial global regulator forms a prion. Front Microbiol (2017) 0.75
Site-specific structural analysis of a yeast prion strain with species-specific seeding activity. Prion (2011) 0.75
Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein. J Korean Med Sci (2014) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Synthetic mammalian prions. Science (2004) 7.35
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell (1989) 4.73
Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet (1961) 4.67
Linkage of prion protein and scrapie incubation time genes. Cell (1986) 3.69
Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol (1982) 3.68
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36
Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
Mapping the prion protein using recombinant antibodies. J Virol (1998) 2.64
Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.38
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol (1987) 2.27
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol (1991) 2.11
Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol (2004) 2.07
Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A (1999) 1.73
The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.66
A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol (2000) 1.65
Identification of two prion protein regions that modify scrapie incubation time. J Virol (2001) 1.63
Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol (2005) 1.43
Autocatalytic conversion of recombinant prion proteins displays a species barrier. J Biol Chem (2003) 1.27
Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol (2002) 0.91
Synthetic mammalian prions. Science (2004) 7.35
Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Genome Biol (2003) 4.24
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36
GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res (2003) 3.34
Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol (2010) 3.19
Prions. Cold Spring Harb Perspect Biol (2011) 3.17
Automated extraction of mutation data from the literature: application of MuteXt to G protein-coupled receptors and nuclear hormone receptors. Bioinformatics (2004) 3.03
Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol (2008) 2.98
Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96
Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69
In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol (2004) 2.59
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41
Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol (2006) 2.38
Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci U S A (2010) 2.37
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol (2002) 2.24
Transmission and detection of prions in feces. J Infect Dis (2008) 2.20
Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A (2013) 2.19
Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14
Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13
Asymptomatic deer excrete infectious prions in faeces. Nature (2009) 2.10
Searching for new antimalarial therapeutics amongst known drugs. Chem Biol Drug Des (2006) 2.10
Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol (2004) 2.07
Transmission of elk and deer prions to transgenic mice. J Virol (2006) 2.03
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A (2009) 1.97
Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A (2005) 1.91
Prion clearance in bigenic mice. J Gen Virol (2005) 1.79
Co-evolutionary analysis reveals insights into protein-protein interactions. J Mol Biol (2002) 1.77
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Prion-associated dilated cardiomyopathy. Arch Intern Med (2005) 1.66
Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66
Copper coordination in the full-length, recombinant prion protein. Biochemistry (2003) 1.66
Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A (2002) 1.65
Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem (2002) 1.64
The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem (2008) 1.64
Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol (2004) 1.63
Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci (2005) 1.62
Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A (2009) 1.59
Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog (2009) 1.58
Is Parkinson's disease a prion disorder? Proc Natl Acad Sci U S A (2009) 1.56
Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord (2007) 1.55
Polio and Nobel prizes: looking back 50 years. Ann Neurol (2007) 1.54
The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry (2010) 1.53
Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog (2011) 1.53
Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51
Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol (2003) 1.51
Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol (2009) 1.51
Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Lab Invest (2009) 1.48
Automatic extraction of protein point mutations using a graph bigram association. PLoS Comput Biol (2007) 1.48
Prions in skeletal muscle. Proc Natl Acad Sci U S A (2002) 1.48
Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem (2006) 1.47
Highly efficient protein misfolding cyclic amplification. PLoS Pathog (2011) 1.46
Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem (2005) 1.45
Molecular phylogeny and evolution of the plant-specific seven-transmembrane MLO family. J Mol Evol (2003) 1.45
Search for a prion-specific nucleic acid. J Virol (2005) 1.44
Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J Mol Biol (2006) 1.44
Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J Biol Chem (2005) 1.44
Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A (2008) 1.43
Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol (2005) 1.43
Inactivation of prions by acidic sodium dodecyl sulfate. J Virol (2006) 1.43
Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc Natl Acad Sci U S A (2011) 1.39
Cytosolic prion protein in neurons. J Neurosci (2003) 1.34
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc Natl Acad Sci U S A (2003) 1.32
Conformational switching within individual amyloid fibrils. J Biol Chem (2009) 1.31
A data processing pipeline for mammalian proteome dynamics studies using stable isotope metabolic labeling. Mol Cell Proteomics (2011) 1.31
Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry (2005) 1.28
Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol (2008) 1.27
A new mechanism for transmissible prion diseases. J Neurosci (2012) 1.25
Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry (2005) 1.25
Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci U S A (2007) 1.25